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Abstract:  
Myosins of class VI (MYO6) are unique actin-based motor proteins that move cargo towards 
the minus ends of actin filaments. As the sole myosin with this directionality, it is critically 
important in a number of biological processes. Indeed, loss or overexpression of MYO6 in 
humans is linked to a variety of pathologies including deafness, cardiomyopathy, 
neurodegenerative diseases as well as cancer. This myosin interacts with a wide variety of 
direct binding partners such as the selective autophagy receptors optineurin, TAX1BP1 and 
NDP52 and also Dab2, GIPC, TOM1 and LMTK2, which mediate distinct functions of different 
MYO6 isoforms along the endocytic pathway. Functional proteomics has recently been used 
to identify the wider MYO6 interactome including several large functionally-distinct multi-
protein complexes, which highlight the importance of this myosin in regulating the actin and 
septin cytoskeleton. Interestingly, adaptor-binding not only triggers cargo attachment, but 
also controls the inactive folded conformation of MYO6. Thus, the C-terminal tail domain 
mediates cargo recognition and binding, but is also crucial for modulating motor activity and 
regulating cytoskeletal track dynamics. 
 
Introduction:  
Myosin motor proteins are powered by ATP hydrolysis to translocate along actin filaments 
and generate force and movement, which is important for a wide range of dynamic 
processes. The human genome contains 39 myosin genes; 15 genes code for “conventional” 
class-II myosins named MYH1 to MYH15. Most of these are expressed in smooth, skeletal or 
cardiac muscle, but three isoforms (MYH9, MYH10 and MYH14) are selectively expressed in 
non-muscle cells (non-muscle myosin IIA, B or C). The remaining 24 genes (MYO1 to MYO19 
including eight class I myosin genes, MYO1A to MYO1H) encode “unconventional” myosins 
and the numbering system corresponds to the 12 different myosin classes established by 
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also called conventional myosins, were the first to be discovered and are the only class to 
form bipolar filaments essential for muscle contraction and generation of contractile forces 
in cells. In contrast, the unconventional myosins fulfil diverse cellular roles, for example, in 
cell migration, vesicle trafficking or cytokinesis by performing tethering functions or short-
range transport. Myosin motor proteins contain a highly conserved motor domain, a neck 
region varying in length that provides bindings sites for up to six calmodulins or related light 
chains, and diverse tail domains for cargo selection linked to specialized functions.  
 
All myosin family members move towards the plus-end of actin filaments, except for the 
unique myosins of class VI (MYO6) [4]. The crystal structure of the MYO6 motor domain 
reveals the presence of an additional insert (insert-2) in the converter domain that 
repositions the lever arm into an orientation to allow “backwards” motion [5]. A second 
unique insert (insert-1) is located near the ATP binding site and modulates ATPase activity 
[5]. The kinetic and biophysical characteristics of this myosin have been well studied at the 
bulk and single molecule level in vitro and have shown that MYO6 is a relatively slow motor 
moving actin filaments approximately 110-140 nm/s [6] [7] [8] [9]. The duty cycle and weak 
gating of this myosin points to its ability to be weakly processive when acting as a dimer [9] 
and suggest that longer ranges of movement probably require several dimers acting in 
unison. Furthermore in the presence of load or high ADP MYO6 has been shown to behave 
more like a molecular anchor than an active transporter [10]. 
 
MYO6 performs a wide range of specialized functions for example in membrane ruffles, on 
early endosomes, on clathrin coated structures at the plasma membrane and at the base of 
microvilli and stereocilia in the inner ear. In humans and mice MYO6 mutations cause a wide 
range of pathologies including hypertrophic cardiomyopathy and hearing loss. Furthermore, 
increased expression of MYO6 has been reported in many different carcinomas [11] [12] 
[13] [14], making it a potential early marker of cancer development.  
 
The multi-functionality of MYO6 requires interaction with a host of binding partners via its 
tail domain, which have been identified using a variety of approaches including yeast-2 
hybrid screens, native co-immunoprecipitation, affinity chromatography using the MYO6 tail 
domain or in situ  proximity labelling [15] [16] [17] [18]. Binding these adaptor proteins is 
crucial for precise spatial and temporal targeting of MYO6. In addition, these adaptor 
proteins may determine whether MYO6 operates in cells as a monomer or a dimer. Purified 
MYO6 in vitro is a monomer, however, association with different binding partners has been 
shown to induce dimerization (figure 1 B) [8] [19] [20]. The tail domain contains several 
unique binding motifs including two adaptor binding domains, two ubiquitin binding regions 
and one lipid binding motif (see figure 1 D). Although most binding partners have been 
shown to bind directly to MYO6, recent work has also suggested that binding might involve 
a variety of ubiquitin chains, which can enhance the affinity and stabilise MYO6-adaptor 
complexes [21] [22]. MYO6 can also directly interact with membranes through its C-terminal 
lipid binding motifs. Overall, the cellular positioning and function(s) of MYO6 are likely to 
involve a combination of lipid and protein binding; sequential or simultaneous binding of 
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ubiquitin chains (see figure 2). This complex process of motor-cargo recognition requires 
tight regulation for initiation and eventually deactivation and recycling of MYO6. 
 
In this article, we discuss the molecular interactions between MYO6 and its binding partners 
and the cellular processes in which they are involved. Moreover, we review the MYO6 
domain organization and recent advances in our understanding of MYO6 regulation.  
 
Cellular functions of MYO6 
 
Diverse roles of MYO6 in the endocytic pathway 
The process of endocytosis permits the uptake of basic nutrients or cell surface receptors 
from the plasma membrane. Several parallel uptake routes have been described including 
clathrin-mediated endocytosis, in which the protein clathrin and associated machinery 
initiate the formation of vesicles from invaginations in the plasma membrane. After 
internalisation the receptor-containing vesicles are delivered to early endosomes and sorted 
either for lysosomal degradation or recycled back to the cell surface. Four splice isoforms of 
MYO6 are expressed in different cell types and tissues, which perform specialised roles at 
distinct steps along the endocytic pathway. These splice variants contain a large insert (LI) 
(adding 21-31 amino acids), a small insert (SI) (adding 9 amino acids), both LI and SI or no 
insert (NI) (see figure 1).  
 
The MYO6 splice variant containing the large insert (LI) at the beginning of the cargo-binding 
domain (CBD) is predominantly expressed in polarised epithelial cells, where it associates 
with clathrin-coated pits or vesicles at the base of microvilli at the apical plasma membrane. 
Indeed, loss of MYO6 expression in the knock out mice (Snell’s waltzer mice) causes defects 
in endocytosis of the cystic fibrosis transmembrane conductance regulator (CFTR) from the 
apical domain of enterocytes, as well as in the uptake of the megalin-receptor in the kidney, 
thereby leading to proteinuria [23] [24] [25].  Interestingly, MYO6 has been shown to 
facilitate the movement of the Na+/H+ exchanger down the microvillus in intestinal cells, as 
well as the movement of sodium transporters in renal proximal tubule cells to allow 
clustering in clathrin-coated pits and endocytosis [26] [27]. MYO6 targeting to clathrin-
coated structures involves the LI splice variant, which constitutes a clathrin-binding domain 
[28], and the clathrin adaptor Dab2 (Disabled-2) [15]. The endocytic adaptor protein, Dab2 
contains a phosphotyrosine binding (PTB) domain that mediates binding to the cytoplasmic 
tail of cell surface receptors. In addition, Dab2 features several binding sites for other 
components of the endocytic machinery. Indeed, in situ proximity labelling using the MYO6 
tail domain identified several proteins associated with clathrin-mediated endocytosis such 
as AP2, ITSN1, SYNJ1, PICALM, EPS15L1 and FCHO2 that are linked to MYO6 through Dab2 
[18].  
 
The isoform of MYO6 without any inserts (NI) is present on a subset of peripheral early 
endosomes, which are positive for the small GTPase Rab5 and the Rab5 effector APPL1 
(Adaptor Protein Phosphotyrosine interacting with PH domain and Leucine Zipper 1) [29] 
[30] [31]. APPL1 is a multifunctional adaptor protein containing multiple domains that 
mediate phospholipid binding and allow interaction with many signalling receptors. At its C-
terminus APPL1 binds to the PDZ domain of GIPC1, which interacts with a large number of 
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other transmembrane proteins. GIPC also binds directly to MYO6 and recruits this myosin to 
APPL1-positive early endosomes [32]. The GIPC1-MYO6 complex has been suggested to 
translocate early endosomes away from the plasma membrane through the cortical actin 
network, since expression of a non-functional MYO6 rigor mutant inhibits endosome 
movement [33] [31] [34]. A crucial role for MYO6 in the spatial organisation of the APPL1-
signalling endosomes is also supported by the findings that the depletion of MYO6 leads to 
the premature maturation and displacement of APPL1 endosomes from the cell cortex in 
the perinuclear region of the cell [35] and expression of a mutant MYO6 that moves towards 
the plus end of actin filaments causes extreme cortical clustering of endosomes [36]. Finally, 
recent in situ proximity experiments identified a tripartite complex of GIPC1, MYO6 and 
LARG, which is a GEF for RHO GTPases. LARG activation downstream of specific G protein 
coupled receptors may link Rho signalling to remodelling of the actin cortex to regulate 
early endosome motility and retrograde movement of internalised receptors [18].  
 
Additional MYO6 adaptor proteins on these early endosomes are TOM1 (Target of Myb 
protein 1) and the related TOM1L2 (Target Of Myb1 Like 2 Membrane Trafficking Protein). 
Both proteins contain a ubiquitin-binding GAT domain and a VHS domain, similar to the 
ESCRT-0 subunits Hrs and STAM. This family of proteins plays an important role in the 
sorting of ubiquitinated cargo destined for lysosomal degradation into late endocytic 
intraluminal vesicles [37]. Targeting of TOM1/L2 to endosomes involves binding to TOLLIP 
(Toll Interacting Protein) and/or endofin, which contains a FYVE domain that binds PI(3)P 
present on early endosomes. Although the exact function of TOM1 and the MYO6/TOM1 
complex is still unclear, TOM1 has been implicated in regulating interleukin-1 and tumour 
necrosis factor-alpha signalling and trafficking [38] [39].  
 
Another MYO6 adaptor in the endocytic pathway is the transmembrane serine/threonine 
kinase LMTK2 (Lemur Tyrosine Kinase 2) [40]. This kinase colocalises with MYO6 on Rab5-
positive endosomes, where it appears to participate in the sorting of receptors from early 
endosomes into the recycling compartment [29]. Little is known about the function of this 
protein compared to other kinases although it has been shown to regulate endocytic 
trafficking, as well as signalling and apoptosis. Changes in LMTK2 expression and function 
are linked to neurodegeneration, cancer and defects in spermatogenesis [41] [42] [43]. At 
present it is not known whether MYO6 activity is regulated through phosphorylation by 
LMTK2 or whether MYO6 mediates the cellular localisation and trafficking of this kinase. 
 
Functions of MYO6 in the exocytic pathway 
In addition to its role in the endocytic pathway, MYO6 appears to play a similarly important 
role in cargo transport in the secretory pathway. In this pathway, proteins synthesized at 
the endoplasmic reticulum are transported in tubular/vesicular carriers to the Golgi 
complex, where they are processed and sorted for delivery to the plasma membrane for 
incorporation or release from the cell. MYO6 localises to vesicles in the perinuclear region 
around the Golgi complex [44] [45] and to vesicles close to the plasma membrane [16]. 
Functional studies using fibroblasts isolated from the Snell’s waltzer mouse reveal a 
significant reduction in Golgi size compared to wild type fibroblasts, combined with a defect 
in constitutive exocytosis [45]. Furthermore, MYO6 is required for the polarised delivery of 
newly synthesized transmembrane proteins to the basolateral plasma membrane domain in 
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MYO6 in the secretory pathway is closely linked to optineurin and the small GTPase Rab8, 
an established optineurin binding partner. The functions of optineurin and MYO6 in 
secretion involve secretory vesicle fusion and possibly fusion pore opening at the plasma 
membrane [48]. In neurosecretory cells the small insert (SI) isoform of MYO6 tethers 
secretory granules to the actin cortex regulated via c-Src phosphorylation [49]. MYO6-
dependent tethering of these secretory granules to the cortical actin network involves 
ENA/VASP scaffolding proteins that are involved in actin polymerisation in addition to 
interactions with other proteins [49, 50].  
 
MYO6 and autophagy 
Autophagy is an essential lysosomal degradation pathway for the breakdown and recycling 
of cytosolic components, which are sequestered in large double-membrane vesicles, called 
autophagosomes. After autophagosome closure, amphisomes are formed by fusion with 
early endosomes, which are believed to deliver essential machinery required for 
autophagosome – lysosome fusion. Autophagy maintains cellular homeostasis and growth 
under conditions of starvation in a non-selective process. This pathway also targets large 
cytosolic objects that are too large to be degraded via the proteasome such as protein 
aggregates, damaged organelles and invading pathogens. These objects are typically marked 
with a ubiquitin tag, which is recognised by selective autophagy receptors through their 
ubiquitin binding domain. The autophagy receptors typically interact with LC3 (Microtubule-
associated Protein 1A/1B-Light Chain 3), triggering the recruitment of LC3-positive 
autophagosomal membranes and thereby capturing the ubiquitinated object inside an 
autophagosome. MYO6 has been shown to bind directly to three of the well-known 
autophagy receptors, optineurin, NDP52 (Nuclear Dot Protein 52 kDa) and TAX1BP1 (Tax1-
Binding Protein 1).  In all three autophagy receptors the ubiquitin-binding site exactly 
overlaps with the MYO6 binding site, however, the binding of TAX1BP1 to MYO6 is stronger 
than the interaction of the autophagy receptor with ubiquitin [51]. These findings are 
consistent with a dual function of the autophagy receptors: first in the recognition and 
capture of ubiquitinated cytosolic objects without MYO6 participation and second in the 
recruitment of this myosin to the outer surface of autophagosomes by binding 
simultaneously to MYO6 and autophagosome-associated LC3. The autophagy receptors and 
TOM1 bind to distinct sites in the MYO6 CBD; pull down experiments have demonstrated 
that the distance between these two binding domains allows simultaneous binding of the 
autophagy receptors and the endosome-anchor TOM1 [52]. These results support the 
model that a ternary complex of MYO6, TOM1 and the autophagy receptors provides a 
mechanism for the tethering of endosomes to autophagosomes to facilitate endosome-
autophagosome fusion and maturation [30].  
 
In addition, MYO6 has a crucial role in xenophagy for the autophagy-dependent clearance of 
pathogens such as Salmonella typhimurium from the cytosol of infected cells [51]. 
Furthermore, during mitophagy, the pathway for removal of non-functional mitochondria 
via autophagy, MYO6 is selectively recruited to damaged mitochondria. MYO6 recruitment 
does not depend on optineurin, TAX1BP1 and NDP52 but requires its ubiquitin-binding 
domain [53]. MYO6 induces the formation of actin cages around damaged mitochondria 
thereby isolating dysfunctional mitochondria destined for mitophagy from the healthy 
network. This novel role for MYO6 is unique to mitophagy, where the actin cages prevent 
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MYO6 adaptor proteins regulate actin track dynamics 
Accumulating evidence indicates that myosin motors do not simply translocate along pre-
existing actin filaments, but also actively induce actin tracks as required. For example, class 
IX myosins (MYO9) have RhoGAP domains in their tails, which regulate RhoGTPase-
dependent modulation of actin dynamics; class V myosins (MYO5) have recently been 
shown to coordinate motor targeting with assembly of actin tracks by binding to the actin 
nucleator SPIRE2, and myosins of class I can interact directly with proteins that regulate 
actin patch formation at the plasma membrane [54] [55] [56]. The recent identification of 
MYO6-associated RhoGEF complexes, which link to different actin modulatory pathways, 
builds significantly on this regulatory theme and highlights the extent to which motor 
activity is synchronised with actin track assembly.  In situ proximity labelling identified 
LRCH1 and LRCH3 of the LRCH (Leucine Rich repeats Calponin Homology domain) family of 
proteins in a complex with MYO6. These proteins comprise a series of N-terminal leucine 
rich repeats (LRRs), involved in protein-protein interactions, and a C-terminal calponin 
homology domain, which can directly bind to actin. LRCH1 and LRCH3 associate directly with 
MYO6 and DOCK7 (Dedicator Of CytoKinesis 7) thus constituting the linker between MYO6 
and DOCK7 [57]. DOCK7 belongs to the DOCK180 family of guanine nucleotide exchange 
factors (GEFs), which catalyse the loading of GTP onto Rho GTPases through a DOCK 
homology region (DHR)-2 domain and thereby activating them [58]. In the case of DOCK7 it 
appears to act as a GEF towards prenylated membrane localised RAC1 (Ras-related C3 
botulinum toxin substrate 1) and CDC42 (Cell division control protein 42), two major 
regulators of the actin cytoskeleton [59]. Functionally, DOCK7 acts predominantly in the 
nervous system and has been implicated in Schwann cell migration, myelination and neurite 
outgrowth [60] [61]. MYO6, LRCH3 and DOCK7 form a tripartite complex, the DISP (DOCK7-
Induced Septin disPlacement) complex [18]. BioID data revealed possible links between 
LRCH3 and septins (SEPT), in particular SEPT7, but also SEPT8, SEPT9, and SEPT10. Septins 
are a large family of GTPases with phospholipid binding activity that assemble into 
filamentous or ring-like structures, which associate with distinct subsets of actin filaments 
and microtubules, as well as membranes of specific curvature and lipid composition [62] 
[63]. Interestingly, overexpression of components of the DISP complex displaces the septins 
from actin filaments and induces the formation of cytosolic actin rings. Dynamic actin 
filaments in membrane ruffles for example are devoid of septin structures, therefore, the 
DISP complex might regulate the removal of septin structures from actin filaments to enable 
actin filament reorganisation through the DOCK7-stimulated RAC1 and CDC42 GTPase 
activity [18].  
 
The second RhoGEF associated with MYO6 is LARG (Leukemia-associated RhoGEF), also 
known as ARHGEF12, which is a RhoA-specific RhoGEF first identified as a fusion product 
with MLL in acute myeloid leukaemia [64]. LARG is among a family of RhoGEFs activated by 
the Gα12/13 G protein subunits and thus mediates RhoA activation downstream of a number 
of receptors.  
 
MYO6 adaptors for specialised functions 
MYO6 also appears to have a number of distinct tissue-specific functions. The interaction 
between MYO6 and SAP97 (Synapse associated Protein 97) has only been reported in 
neuronal tissues so far [65]. Indeed, MYO6 has been identified in a complex with SAP97 and 
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delivery or endocytosis of the receptors to or from the cell surface in an activity-dependent 
fashion [66] [67] [65].  
 
In inner ear hair cells, MYO6 binds to otoferlin, a transmembrane protein and putative Ca2+ 
sensor of synaptic exocytosis.  The otoferlin-MYO6 complex has been suggested to 
participate in targeting neurotransmitter vesicles to the specialised ribbon synapses at the 
basolateral membrane of these hair cells for exocytosis and signal transmission to ganglia 
neurons [68] [69]. Since mutations in both MYO6 and otoferlin cause deafness in humans, 
this suggests a complementary role for these proteins in normal hair cell function in the ear 
[70] [71].  
 
A yeast two-hybrid screen has identified phospholipase C (PLCδ3), an important enzyme in 
phosphoinositide metabolism, as a MYO6 binding partner [72]. Although PLCδ3 is also 
expressed in inner ear hair cells, no hearing abnormalities were observed in the PLCδ3 KO 
mouse. The expression of MYO6, however, is decreased in the intestine of the PLCδ3 KO 
mouse and loss of the enzyme decreases the number of microvilli in the small intestine. 
Thus, a functional complex of PLCδ3 and MYO6 may be required for maintenance of apical 
microvilli in polarised epithelial cells [72]. 
 
Finally, MYO6 has also been suggested to function together with the putative transcription 
co-activator NDP52 in the nucleus and to regulate RNA polymerase II-dependent 
transcription [73] [74].  
 
 
MYO6 Molecular interactions 
 
A limited data set of structural information is available on the tail domain with or without 
their binding partners [20] [21] [75]. To date, cryo-EM has been successfully applied to the 
motor domain bound to actin filaments [76], but this technique has yet to be used on the 
flexible tail domain. 
 
The cargo-binding tail domain contains protein-binding motifs, ubiquitin-binding sites and a 
phospholipid binding domain (see figure 1 D and figure 2). The first MYO6 protein-binding 
motif, the adaptor binding domain 1 (ABD1), encompasses the RRL1116-1118 motif (positions 
refer to canonical MYO6 sequence Q9UM54-3 uniprot) and the second protein-binding 
domain, the adaptor binding domain 2 (ABD2) contains the WWY1201-1203 motif [20] [21] 
[75]. Point mutations in the RRL motif inhibit MYO6 binding to GIPC, NDP52, TAX1BP1 and 
optineurin [16] [77] [78]. Dab2, LMTK and TOM1 proteins all interact with MYO6 via ABD2, 
which includes the WWY motif [15] [29] [30]. The tail also contains two ubiquitin binding 
sites, a Motif Interacting with Ubiquitin (MIU)990-1014 and a Myosin VI Ubiquitin-Binding 
Domain (MyUb)998-1025, which overlaps with the ABD11084-1128 and the lipid binding 
domain1122-1131 (PIP2) [20] [78, 79] [21]. Through the ABD1/MyUb domain MYO6 can 
interact directly with adaptor proteins such as GIPC, TAX1BP1, NDP52 and optineurin [52] 
[16] [51]. In addition, the MyUb may allow indirect binding via ubiquitin chains to other 
proteins. This may involve direct binding of MYO6 to, for example, ubiquitinated proteins on 
the outer mitochondrial membrane or indirect binding via free ubiquitin chains, which may 
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TOM1, TAX1BP1, optineurin and NDP52 [53] [21]. The MYO6 CBD contains two 
phosphorylation sites TINT1096-1100 and DYD1145-1147.  Phosphomimetic mutations of the TINT 
to EINE inhibited the binding of MYO6 to optineurin, suggesting that phosphorylation of 
MYO6 at this site might regulate binding of adaptor proteins to ABD1 [16]. The different 
splice variants of MYO6 allow additional regulatory mechanisms by providing extra 
regulatory phosphorylation motifs or adaptor protein binding sites. For example, the DYD 
motif is a potential c-src-kinase phosphorylation site only present in the MYO6 SI isoform, 
which regulates tethering of secretory granules to the actin cortex in PC-12 cells [49]. The LI 
isoform is located prior to the ABD1/MyUB domain and forms a unique regulatory 
amphipathic α-helix that contains a clathrin-binding site [28]. This helix also provides steric 
hindrance for binding of the adaptor proteins GIPC, NDP52, TAX1BP1 and optineurin to the 
ABD1 [28]. Between the ABD1 and ABD2 in the tail there is a large unstructured region, 
which may increase flexibility for cargo-binding to allow different adaptor proteins to bind 
simultaneously. Furthermore, protein binding itself may induce unique structural re-
organisation, as binding of MYO6 to lipids leads to an increased presence of α-helices in the 
tail domain [78]. In the next section, we will focus on the interaction of MYO6 with various 
cargo adaptors and the effect on its oligomerization state which is important for its function 
as an anchor or transporter. Upon purification MYO6 appears to be a monomer in vitro [8], 
however, the interaction with different cargo-adaptor proteins may induce dimerization or 
even oligomerization (see figure 1B) [75] [19] [20], and thus determine the detailed cellular 
roles and functions of MYO6 as a monomer or  dimer. 
 
MYO6 ABD1 and MyUb domain encompassing the RRL motif 
GIPC binds directly to the ABD1 [78]. In its inactive form GIPC exists as an autoinhibited 
dimer, which opens up upon cargo binding to interact with the RRL motif in MYO6 [20]. The 
GIPC-MYO6 complex can assemble into linear higher-order oligomers, in which GIPC binds 
via its C-terminal GIPC-homology 2 (GH2) domain to the RRL motif, which is embedded in 
the middle of the second α-helix in MYO6 ABD21084-1128. The GH2 of the first GIPC molecule 
interacts with the two arginines (RR1116,1117) of the RRL motif and an extended region to 
allow hydrophobic interactions [20]. The GH2 domain of the second GIPC molecule binds to 
the opposite side of the MYO6 CBD covering the leucine (L1118) of the RRL motif allowing the 
formation of five, or even longer, linear GIPC-MYO6 oligomers. In vivo observations support 
the importance of MYO6 oligomerization induced by GIPC through a mutant MYO6+ that 
moves towards the plus end of actin filaments. MYO6+ induced filopodia formation only 
occurs in the presence of GIPC, which accumulates together with MYO6+ at the tips [36]. 
Interestingly, an artificially dimerised MYO6 without the CBD, can rescue this phenotype, 
which supports the importance of GIPC-mediated dimerization/oligomerisation for MYO6 
functions in vivo.  
 
Direct binding of GIPC, but also the other adaptor proteins to the ABD1 not only requires 
the RRL motif but also the neighbouring extended hydrophobic surface1123-1131 [21]. 
Interestingly, this region is dispensable for ubiquitin binding, but essential for direct adaptor 
binding. Furthermore, the presence of the extra α-helix introduced by the LI isoform inhibits 
binding of these four direct binding partners to MYO6, as it excludes their binding to the 
second arginine and leucine (RL1117,1118) of the RRL motif [28]. In contrast to GIPC, NDP52, 
TAX1BP1 and optineurin not only interact directly with MYO6 [52] [51], but potentially also 
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with K48, K63, K29 and K11 linked ubiquitin chains, with a clear preference for the latter 
three [21]. Both MYO6 and TAX1BP1 have been shown to bind to K63 Ub4 chains 
simultaneous, thus forming a MYO6-ubiquitin-TAX1BP1 complex [22]. Therefore, the 
interaction of MYO6 with the autophagy receptors may have extra regulation via ubiquitin 
chains.  
 
Finally, MYO6 can also directly interact with ubiquitinated proteins via the MyUb or the MIU 
binding motif in the absence of any of the known cargo-adaptor proteins. MYO6 MyUb 
recognizes and directly interacts with ubiquitinated mitochondria marked for degradation 
by Parkin in vivo [22]. The MIU binding motif shows no affinity or preference towards 
ubiquitin linkages; however, in cooperation with the MyUb domain it seems to specifically 
support K11-linked ubiquitin binding.   
 
MYO6-adaptor interaction at the WWY binding motif 
The interaction of MYO6 with the clathrin adaptor Dab2 for example, has been suggested to 
induce dimerization of MYO6 [75]. Targeting of MYO6 to clathrin-coated structures at the 
plasma membrane involves Dab2-binding via the WWY and IWE1261-1263 protein-interaction 
motifs within the ABD2, and binding to PtdIns(4,5)P2 via the phospholipid domain
1122-1131 
(PIP2) [75] [80] [81] [52]. In addition, MYO6 may interact directly with clathrin through a 
binding region that has been identified in the α2-linker helix of the LI splice isoform [28]. 
The MYO6 CBD contains two discrete spatially separated Dab2 binding sites, site I (including 
the WWY motif) and site II (including the IWE motif). Structural data suggests that Dab2 may 
induce dimerization of MYO6 by binding to the WWY motif on one MYO6 monomer and the 
IWE motif of another [75]. The remaining two binding sites on the two MYO6 monomers are 
occupied by a second Dab2 in the reverse orientation thereby stabilising the dimer. Site I is 
the major binding site, allowing hydrophobic interactions between Dab2 and MYO6, 
whereas binding site II interacts with Dab2 through both charge and hydrophobic 
interactions thereby increasing the binding affinity [75]. Point mutations of the tryptophan 
of either binding motif, W1202 of WWY or W1262 of IWE, disrupt Dab2 binding to MYO6 and 
abolish cellular localization to clathrin-coated structures at the plasma membrane in vivo 
[75] [52]. The importance of site I was confirmed by in situ proximity labelling, which 
demonstrated the loss of Dab2 and other proteins associated with clathrin-mediated 
endocytosis upon mutation of the WWY site [18]. 
 
TOM1 also binds to the WWY motif in the ABD2, as determined by pull downs and 
mammalian 2-hybrid in vitro [30]. MYO6 may simultaneously interact, through its ABD1 with 
the LC3-binding autophagy receptors (NDP52, TAX1BP1 and optineurin) and through the 
WWY motif in ABD2 with TOM1-positive endocytic vesicles [82]. Indeed, in vitro 
experiments using purified proteins have shown that two adaptor proteins such as TOM1 
and NDP52 can bind simultaneously directly to the MYO6 ABD1 and the ABD2  [52]. 
Interestingly, in situ proximity labelling of MYO6 NI CBD has indicated that the mutation of 
the RRL motif also leads to the loss of TOM1, and its partner TOLLIP [18]. These results 
suggest that although the interaction between TOM1 and MYO6 occurs directly via the 
WWY motif, in vivo the binding between MYO6 and TOM1 may also be indirect via ubiquitin 
using the ubiquitin-binding TOM1 VHS domain and the MYO6 MyUb domain. A detailed 
structural and biochemical analysis is required, to distinguish whether the MYO6-TOM1 
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Potential mechanisms for regulation of MYO6 motor activity  
 
All myosin motors, with the exception of class XVIII (MYO18) [83], are actin-activated 
ATPases, and this prevents futile ATP hydrolysis when the motor is not attached to actin 
filaments. To further control random non-productive translocation along the dense cellular 
actin network, tight regulation of myosin mobilisation is required. Several layers of 
regulation are present in most myosins, some being unique and other being universal across 
the myosin family to coordinate the timing of cargo binding with activation of ATP 
hydrolysis and force production.   
 
Actin track composition 
The actin filament track composition provides the first layer of regulation as myosin activity 
is responsive to the actin isoform involved, the actin binding proteins present and the 
nucleotide-state of the actin monomer.  
 
Actin filaments are highly dynamic structures that assemble by the addition of new ATP-
actin monomers to the plus-end of filaments at the plasma membrane or the surface of 
internal membranes. Through the constant addition of new ATP-actin the filaments undergo 
retrograde flow and sequential ATP-hydrolysis, referred to as filament ageing. Whereas ATP-
actin and ADP-Pi actin filaments have very similar properties, the ADP-actin accumulating at 
the minus end of the filament is less rigid and stable. Interestingly, in vitro MYO5 shows 
increased run lengths on ADP+Pi-rich filaments, whereas MYO6 which prefers ‘old’ ADP-rich 
filaments [6]. Recent cryo-EM structures confirm minor conformational changes between 
nucleotide states of F-actin [84], as well as within the actin binding interface of the motor 
domain of non-muscle myosin class IIc (MYH14) and MYO6. [85] [76].   
 
From the six different actin isoforms expressed in mammalian cells, four isoforms are only 
present in muscle cells. The two cytoplasmic actin isoforms (-cyto and -cyto) are found in 
most cell types and tissues. Although these two cytoplasmic actins only differ by four 
residues in their N-terminal sequence, they can assemble into distinct actin structures in 
non-muscle cells and preferentially associate with different classes of myosins. At present it 
is not known whether MYO6 is differentially activated by different actin isoforms, however, 
non-muscle myosin IIc (MYH14) shows increased kinetics when interacting with cytoplasmic 
β-actin whereas ATPase activity of MYO7A  results in greater stimulation by γ-actin [86].  
 
Activation of select myosin motors is not only influenced by the actin isoforms that 
make up a filament, but is also regulated by a large number of actin binding proteins. In this 
respect the most important one is probably tropomyosin, which has been well-characterised 
together with troponin for its role in Ca2+ regulation of sarcomeric myosins of class II in 
striated muscle. In non-muscle cells 40 tropomyosin (Tm) isoforms have been identified, 
which decorate spatially and temporally distinct actin filament assemblies [87] [88]. The 
presence of these tropomyosin isoforms on different actin structures modulates the affinity 
of myosin motors and leads to the select recruitment of specialised myosins to functionally 
distinct actin filaments. For example, myosin class Ic (MYO1C) does not bind to actin 
filaments containing Tm2, whereas MYO5A selectively engages with Tm3.1 –decorated actin 
filaments [89] [90]. Future studies will show whether MYO6 preferentially binds to different 
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Regulation of MYO6 through phosphorylation 
In addition to the regulation of motor activity through crosstalk with the actin filament 
track, post-translational modifications of the myosin heavy chain or associated light chains 
are another important regulatory mechanism. For example, non-muscle MYO2s are 
regulated by phosphorylation of the regulatory light chains by a variety of kinases, which 
trigger dramatic structural changes of the myosin from a folded inactive state to an 
unfolded active state [91]. In Acanthamoeba, several of the myosin class I family members 
(myosin Ia, b and c) have been shown to be regulated by phosphorylation at a single serine 
or threonine in the motor which enhances the actin activated ATPase [92]. This site obeys 
the TEDS rule (it must either be a Thr, Glu, Asp or Ser) for myosin motor domain 
phosphorylation postulated by Bement and Mooseker [93]. MYO6 is also phosphorylated at 
Thr405 in the cardiomyopathy loop in the actin binding region, and this phosphorylation 
event affects the KATPASE but not the Vmax [9]. Phosphorylation in the MYO6 motor domain 
occurs downstream of growth factor receptor activation and is accompanied by its 
recruitment to membrane ruffles [44]. Moreover, Salmonella virulence effectors, such as 
SopE, have been suggested to activate MYO6 through PAK-dependent phosphorylation at 
Thr405 [94]. 
 
Backfolding regulates ATPase kinetics 
Backfolding as a way to inactivate ATP hydrolysis is a recurring theme in the myosin family 
(II, V, VI, VII and X) [95] [96] [97]. MYO5 has been shown to take a compact conformation, 
where the tail back-folds onto the motor domain, in this conformation the ATPase activity is 
reduced 50-fold [98]. In the case of MYO5 this backfolding is regulated by calcium binding 
to, and changing the conformation of calmodulin bound to the neck domain.  
 
MYO6 has two calmodulins bound at the neck domain. The first calmodulin is a structural 
calmodulin that is ‘locked’ into the molecule. The second calmodulin has been shown to 
change conformation depending on the number of Ca2+ ions bound. Upon binding Ca2+ one 
lobe detaches from the heavy chain and rebinds to a higher affinity binding site present in 
the 3-helix bundle  at the beginning of the tail [97]. This has the effect of “breaking” the 
lever arm, so the molecule cannot translocate cargo, simultaneously the tail domain enters 
into a “primed” position making it more readily able to bind cargo [97]. In the absence of 
cargo, and in a return to the low Ca2+ condition the molecule will retake a compact 
backfolded conformation, if cargo is bound the restored lever arm can now facilitate active 
translocation. The backfolded molecule can also unfold in the presence of high 
concentrations of binding partners similar to MYO5 [99], this may simply be a matter of 
shifting equilibriums between the inactive and active state, however, on its own this is 
probably not an effective method of regulation within the cell. 
 
Conclusion and Perspectives 
The unique mechanical and biochemical characteristics of MYO6 make it a motor that 
cannot easily be replaced in the cell. MYO6 binds a large range of cargoes and acts as a hub 
in a number of protein networks linked to different cellular pathways. With recent advances 
in functional proteomics we believe that an even greater number of transient, short-lived 
interactions will be discovered, further highlighting that MYO6 is the linchpin in many 











This article is protected by copyright. All rights reserved. 
Although some progress has been made with the understanding of the regulation of MYO6, 
the mechanisms which constrict the selection, substitution and release of cargo are still not 
understood. Answering these questions as well as further structural details, in particular of 
the cargo binding domain, are crucial for using MYO6 as a future therapeutic target to 
improve human health.  
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Figure 1: MYO6 structure and interaction with binding partners. A. Cartoon of MYO6 
structure, denoting its cargo binding domain (CBD). B-C. MYO6 functions during transport 
and tethering with various bindings partners and oligomerization states. B. Monomeric 
TOM1 may interact with one MYO6 monomer; two Dab2 monomers may dimerize MYO6 or 
one optineurin dimer can bind two MYO6 monomers; native dimer GIPC may oligomerize 
MYO6. C. MYO6 interacts with PIP2, clathrin and Dab2 in clathrin-mediated endocytosis; 
MYO6 may interact simultaneously with TOM1 and NDP52 or TAX1BP1 and optineurin to 
drive autophagosome maturation; MYO6 interacts with ubiquitin (UB) on mitochondria 
during mitophagy. D. MYO6 amino acid sequences based on the human no insert (NI), small 
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annotated above the sequences. Predicted secondary structures are shown on top of the 
sequences; grey lines, zigzags and arrows represent unstructured regions, α-helices and β-
sheets respectively (modified from [28] [75] [81]). MYO6 interaction regions are shown for 
GIPC (orange), Dab2 (green) and K63-linked diubiquitin (purple) (based on structural data of 
[75] [20] [21]. Small (grey) dots refer to every 10th amino acid.  
 
Figure 2: Cartoon highlighting binding sites in the MYO6 CBD. Schematic of the cellular 
processes in which MYO6 is implicated through direct (blue) and indirect (grey) binding 
partners. In autophagy, MYO6 interacts directly with autophagy receptors TAX1BP, NDP52 
and optineurin through its RRL domain (orange) or indirectly by binding to ubiquitin via its 
MyUb domain (purple dotted lines). Ubiquitin (UB) binding is also required during 
mitophagy (purple). A second ubiquitin-binding domain (MIU) allows binding to selective 
ubiquitin chains. In early stages of endocytosis, MYO6 interacts with LMTK2, TOM1/L2 and 
Dab2 via its WWY motif (green). Dab2-mediated dimerization also involves the IWE motif 
(green dotted line). MYO6 binds to lipids through its PIP2 domain and to clathrin via the 
clathrin-binding region present in the LI isoform. MYO6 is recruited via GIPC to APPL1-
positive signalling endosomes, or linked via GIPC to LARG and SHBP4 potentially regulating 
GPCR signalling. MYO6 binding to LRCH3 provides a link to regulation of actin and septin 
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